Cheng Qian
- Cancer Research top 1%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 4
- Immunology top 5%
- Immune Response and Inflammation 3
- interferon and immune responses 2
- Molecular Biology top 5%
- Circular RNAs in diseases 4
-
- Pelvic floor disorders treatments 3
-
- Vitamin D Research Studies 2
- Co-authors
- Xuetao CaoJuan LiuJin HouYizhi YuYan GuXiaoping SuDan HanNan Li
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Cheng Qian
45 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 1.1k
- Immunology 550
- Molecular Biology 1.5k
- Oncology 163
- Geriatrics and Gerontology 19
Countries citing papers authored by Cheng Qian
This map shows the geographic impact of Cheng Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Qian more than expected).
Fields of papers citing papers by Cheng Qian
This network shows the impact of papers produced by Cheng Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Qian. The network helps show where Cheng Qian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 5 | |
| 11 | 2019 | 20 | |
| 12 | 2016 | 10 | |
| 13 | Post-Translational Modification Control of Innate Immunitybreakdown → | 2016 | 440 |
| 14 | 2014 | 1 | |
| 15 | 2014 | 17 | |
| 16 | 2013 | 56 | |
| 17 | 2012 | 17 | |
| 18 | 2011 | 3 | |
| 19 | 2008 | 3 | |
| 20 | 2006 | 212 |
About Cheng Qian
Cheng Qian is a scholar working on Cancer Research, Critical Care and Intensive Care Medicine and Pathology and Forensic Medicine, having authored 48 papers that have together received 2.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Circular RNAs in diseases (4 papers), Pelvic floor disorders treatments (3 papers), Immune Response and Inflammation (3 papers), interferon and immune responses (2 papers) and Vitamin D Research Studies (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (550 citations) and Molecular Biology (1.5k citations). Cheng Qian has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xuetao Cao, Juan Liu, Jin Hou, Yizhi Yu, Yan Gu, Xiaoping Su, Dan Han, Nan Li, Jiangxue Li and Yun Lin. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.